Beta 3 adrenergic receptors: Molecular, histological, functional and pharmacological approaches

Romanian Journal of Morphology and Embryology

Volumn 50, Issue 2, 2008, Pages 169-179

  Coman, Oana Andreia ^a   Paunescu H ^a   Ghiţǎ, Isabel ^a   Coman, L ^a   Bǎdǎrǎru, Anca ^a   Fulga, I ^a  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Beta 3 adrenergic receptors; Discovery; Histology; Molecular biology; Pharmacology; Physiology

Indexed keywords

ADRENALIN; BETA 3 ADRENERGIC RECEPTOR; NORADRENALIN;

ANIMAL; ANTIBODY SPECIFICITY; CHEMISTRY; ENERGY METABOLISM; GENETICS; GLYCOSYLATION; HUMAN; LIPID METABOLISM; METABOLISM; PHYSIOLOGY; PROTEIN CONFORMATION; REVIEW;

ANIMALS; ENERGY METABOLISM; EPINEPHRINE; GLYCOSYLATION; HUMANS; LIPID METABOLISM; NOREPINEPHRINE; ORGAN SPECIFICITY; PROTEIN CONFORMATION; RECEPTORS, ADRENERGIC, BETA-3;

EID: 70249137244     PISSN: 12200522     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. LANDS A. M., LUDUENA F. P., BUZZO H. J., Differentiation of receptors responsive to isoproterenol, Life Sci, 1967, 6(21):2241-2249.
2. HARMS H. H., ZAAGSMA J., DE VENTE J., Differentiation of beta-adrenoceptors in right atrium, diaphragm and adipose tissue of the rat, using stereoisomers of propranolol, alprenolol, nifenalol and practolol, Life Sci, 1977, 21(1):123-128.
3. FURMAN B. L., TAYO F. M., Effect of some beta adrenoceptors blocking drugs on insulin secretion in the rat, J Pharm Pharmacol, 1974, 26:512-517.
4. AHRÉN B., LUNDQUIST I., Effects of selective and non- selective beta-adrenergic agents on insulin secretion in vivo, Eur J Pharmacol, 1981, 71(1):93-104.
5. COLEMAN R. A., DENYER L. H., SHELDRICK K. E., Beta- Adrenoceptors in guinea-pig gastric fundus - are they the same as the 'atypical' β-adrenoceptors in rat adipocytes?, Br J Pharmacol, 1987, 90:40P.
6. BLUE D. R., BOND R. A., ADHAM N., DELMENDO R., MICHEL A. D, EGLEN R. M., WHITING R. L., CLARKE D. E., Antagonist characterization of atypical beta adrenoceptors in guinea pig ileum: blockade by alprenolol and dihydroal-prenolol, J Pharmacol Exp Ther, 1990, 252(3):1034-1042.
7. CROCI T., CECCHI R., TARANTINO A., AUREGGI G., BIANCHETTI A., BOIGEGRAIN R., MANARA L., Inhibition of rat colon motility by stimulation of atypical beta-adrenoceptors with new gut-specific agents, Pharmacol Res Commun, 1988, 20(2):147-151.
8. TAN S., CURTIS-PRIOR P. B., Characterization of the beta- adrenoceptor of the adipose cell of the rat, Int J Obes, 1983, 7(5):409-414.
9. ARCH J. R., AINSWORTH A. T., CAWTHORNE M. A., PIERCY V., SENNITT M. V., THODY V. E., WILSON C., WILSON S., Atypical beta-adrenoceptor on brown adipocytes as target for anti- obesity drugs, Nature, 1984, 309(5964):163-165.
10. EMORINE L. J., MARULLO S., BRIEND-SUTREN M. M., PATEY G., TATE K., DELAVIER-KLUTCHKO C., STROSBERG A. D., Molecular characterization of the human beta 3-adrenergic receptor, Science, 1989, 245(4922):1118-1121.
11. SWARBRICK J., BOYLAN J. C., Encyclopedia of Pharmaceutical Technology: A-D, Vol. 1, Informa Health Care, New York, 2002, 212-213.
12. VAUQUELIN G., GEYNET P., HANOUNE J., STROSBERG A. D., Isolation of adenylate cyclase-free, beta-adrenergic receptor from turkey erythrocyte membranes by affinity chromatography, Proc Natl Acad Sci U S A, 1977, 74(9):3710-3714.
13. STILES G. L., BENOVIC J. L., CARON M. G., LEFKOWITZ R. J., Mammalian beta-adrenergic receptors. Distinct glyco- protein populations containing high mannose or complex type carbohydrate chains, J Biol Chem, 1984, 259(13):8655-8663.
14. DIXON R. A., KOBILKA B. K., STRADER D. J., BENOVIC J. L., DOHLMAN H. G., FRIELLE T., BOLANOWSKI M. A., BENNETT C. D., RANDS E., DIEHL R. E., MUMFORD R. A., SLATER E. E., SIGAL I. S., CARON M. G., LEFKOWITZ R. J., STRADER C. D., Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin, Nature, 1986, 321(6065):75-79.
15. YARDEN Y., RODRIGUEZ H., WONG S. K., BRANDT D. R., MAY D. C., BURNIER J., HARKINS R. N., CHEN E. Y., RAMACHANDRAN J., ULLRICH A. et al., The avian beta- adrenergic receptor: primary structure and membrane topology, Proc Natl Acad Sci U S A, 1986, 83(18):6795-6799.
16. PEREZ M. D. (ed), The adrenergic receptors in the 21st century, Humana Press, Inc., Totowa, New Jersey, 2005, 151-152.
17. DONALDSON L. F., Identification of G-protein-coupled receptor mRNA expression by Northern blotting and in situ hybridization, Methods Mol Biol, 2004, 259:99-122.
18. BURNETTE W. N., "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A, Anal Biochem, 1981, 112(2):195-203.
19. JIN L., LLOYD R. V., In situ hybridization: methods and applications, J Clin Lab Anal, 1997, 11(1):2-9.
20. PERKINS J. P. (ed), The beta-adrenergic receptors series: the receptors, Humana Press, Inc., Clifton, New Jersey, 1991, 4-7.
21. SKEBERDIS V. A., Structure and function of beta3-adrenergic receptors, Medicina (Kaunas), 2004, 40(5):407-413.
22. ***, β3-Adrenoceptors, website http://www.uni-graz.at/binder/science/b3adrenoceptors.html, 2009.
23. NAHMIAS C., BLIN N., ELALOUF J. M., MATTEI M. G., STROSBERG A. D., EMORINE L. J., Molecular characterization of the mouse beta 3-adrenergic receptor: relationship with the atypical receptor of adipocytes, EMBO J, 1991, 10(12):3721-3727.
24. STROSBERG A. D. (ed), The β3-adrenoceptor, Taylor & Francis, CRC Press, London, 2000.
25. STROSBERG A. D., Structure, function, and regulation of adrenergic receptors, Protein Sci, 1993, 2(8):1198-1209.
26. EVANS B. A., PAPAIOANNOU M., HAMILTON S., SUMMERS R. J., Alternative splicing generates two isoforms of the beta3-adrenoceptor which are differentially expressed in mouse tissues, Br J Pharmacol, 1999, 127(6):1525-1531.
27. SHIMIZU Y., TANISHITA T., MINOKOSHI Y., SHIMAZU T., Activation of mitogen-activated protein kinase by norepinephrine in brown adipocytes from rats, Endocrinology, 1997, 138(1):248-253.
28. CAO W., MEDVEDEV A. V., DANIEL K. W., COLLINS S., beta-Adrenergic activation of p38 MAP kinase in adipocytes: cAMP induction of the uncoupling protein 1 (UCP1) gene requires p38 MAP kinase, J Biol Chem, 2001, 276(29):27077-27082.
29. NANTEL F., MARULLO S., KRIEF S., STROSBERG A. D., BOUVIER M., Cell-specific down-regulation of the beta 3-adrenergic receptor, J Biol Chem, 1994, 269(18):13148-13155.
30. BENGTSSON T., CANNON B., NEDERGAARD J., Differential adrenergic regulation of the gene expression of the beta-adrenoceptor subtypes beta1, beta2 and beta3 in brown adipocytes, Biochem J, 2000, 347(Pt 3):643-651.
31. REVELLI J. P., MUZZIN P., GIACOBINO J. P., Modulation in vivo of beta-adrenergic-receptor subtypes in rat brown adipose tissue by the thermogenic agonist Ro 16-8714, Biochem J, 1992, 286(Pt 3):743-746.
32. GRANNEMAN J. G., Effects of agonist exposure on the coupling of beta 1 and beta 3 adrenergic receptors to ade- nylyl cyclase in isolated adipocytes, J Pharmacol Exp Ther, 1992, 261(2):638-642.
33. LIGGETT S. B., FREEDMAN N. J., SCHWINN D. A., LEFKOWITZ R. J., Structural basis for receptor subtype- specific regulation revealed by a chimeric beta 3/beta 2- adrenergic receptor, Proc Natl Acad Sci U S A, 1993, 90(8):3665-3669.
34. DIXON T. M., DANIEL K. W., FARMER S. R., COLLINS S., CCAAT/enhancer-binding protein alpha is required for transcription of the beta 3-adrenergic receptor gene during adipogenesis, J Biol Chem, 2001, 276(1):722-728.
35. KUTOH E., ONGENAE N., CLAESKENS A., VERHEYEN W., CHEYNS P., NEEFS J., KAIJEN P., A putative white adipose tissue specific nuclear orphan receptor that interacts with the cAMP-response element of the human beta3- adrenergic receptor gene, Mol Cell Endocrinol, 2000, 165(1-2):85-95.
36. RODRIGUEZ M., CARILLON C., COQUEREL A., LE FUR G., FERRARA P., CAPUT D., SHIRE D., Evidence for the presence of beta 3-adrenergic receptor mRNA in the human brain, Brain Res Mol Brain Res, 1995, 29(2):369-375.
37. DENG C., PAOLONI-GIACOBINO A., KUEHNE F., BOSS O., REVELLI J. P., MOINAT M., CAWTHORNE M. A., MUZZIN P., GIACOBINO J. P., Respective degree of expression of beta 1-, beta 2- and beta 3-adrenoceptors in human brown and white adipose tissues, Br J Pharmacol, 1996, 118(4):929-934.
38. KAUMANN A. J., (-)-CGP 12177-induced increase of human atrial contraction through a putative third beta- adrenoceptor, Br J Pharmacol, 1996, 117(1):93-98.
39. GAUTHIER C., TAVERNIER G., CHARPENTIER F., LANGIN D., LE MAREC H., Functional beta 3-adrenoceptor in the human heart, J Clin Invest, 1996, 98(2):556-562.
40. TAGAYA E., TAMAOKI J., TAKEMURA H., ISONO K., NAGAI A., Atypical adrenoceptor-mediated relaxation of canine pulmonary artery through a cyclic adenosine monophos- phate-dependent pathway, Lung, 1999, 177(5):321-332.
41. BERLAN M., GALITZKY J., BOUSQUET-MELOU A., LAFONTAN M., MONTASTRUC J. L., Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog, J Pharmacol Exp Ther, 1994, 268(3):1444-1451.
42. HOM G. J., FORREST M. J., BACH T. J., BRADY E., CANDELORE M. R., CASCIERI M. A., FLETCHER D. J., FISHER M. H., ILIFF S. A., MATHVINK R., METZGER J., PECORE V., SAPERSTEIN R., SHIH T., WEBER A. E., WYVRATT M., ZAFIAN P., MACINTYRE D. E., Beta(3)- adrenoceptor agonist-induced increases in lipolysis, metabolic rate, facial flushing, and reflex tachycardia in anesthetized rhesus monkeys, J Pharmacol Exp Ther, 2001, 297(1):299-307.
43. TROCHU J. N., LEBLAIS V., RAUTUREAU Y., BÉVÉRELLI F., LE MAREC H., BERDEAUX A., GAUTHIER C., Beta 3- adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta, Br J Pharmacol, 1999, 128(1):69-76.
44. RAUTUREAU Y., TOUMANIANTZ G., SERPILLON S., JOURDON P., TROCHU J. N., GAUTHIER C., Beta 3-adrenoceptor in rat aorta: molecular and biochemical characterization and signalling pathway, Br J Pharmacol, 2002, 137(2):153-161.
45. BERLAN M., GALITZKY J., MONTASTRUC J. L., Beta 3- adrenoceptors in the cardiovascular system, Fundam Clin Pharmacol, 1995, 9(3):234-239.
46. ROZEC B., SERPILLON S., TOUMANIANTZ G., SÈZE C., RAUTUREAU Y., BARON O., NOIREAUD J., GAUTHIER C., Characterization of beta3-adrenoceptors in human internal mammary artery and putative involvement in coronary artery bypass management, J Am Coll Cardiol, 2005, 46(2):351-359.
47. DESSY C., MONIOTTE S., GHISDAL P., HAVAUX X., NOIRHOMME P., BALLIGAND J. L., Endothelial beta3- adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-depen- dent hyperpolarization, Circulation, 2004, 110(8):948-954.
48. SUMMERS R. J., PAPAIOANNOU M., HARRIS S., EVANS B. A., Expression of beta 3-adrenoceptor mRNA in rat brain, Br J Pharmacol, 1995, 116(6):2547-2548.
49. CASTILLO-MELÉNDEZ M., MCKINLEY M. J., SUMMERS R. J., Intracerebroventricular administration of the beta(3)-adreno- ceptor agonist CL 316243 causes Fos immunoreactivity in discrete regions of rat hypothalamus, Neurosci Lett, 2000, 290(3):161-164.
50. LENARD N. R., GETTYS T. W., DUNN A. J., Activation of beta2- and beta3-adrenergic receptors increases brain tryptophan, J Pharmacol Exp Ther, 2003, 305(2):653-659.
51. GEYER O., BAR-ILAN A., NACHMAN R., LAZAR M., ORON Y., Beta3-adrenergic relaxation of bovine iris sphincter, FEBS Lett, 1998, 429(3):356-358.
52. STEINLE J. J., BOOZ G. W., MEININGER C. J., DAY J. N., GRANGER H. J., Beta 3-adrenergic receptors regulate retinal endothelial cell migration and proliferation, J Biol Chem, 2003, 278(23):20681-20686.
53. ARCH J. R., KAUMANN A. J., Beta 3 and atypical beta- adrenoceptors, Med Res Rev, 1993, 13(6):663-729.
54. LEZAMA E. J., KONKAR A. A., SALAZAR-BOOKAMAN M. M., MILLER D. D., FELLER D. R., Pharmacological study of atypical beta-adrenoceptors in rat esophageal smooth muscle, Eur J Pharmacol, 1996, 308(1):69-80.
55. MANARA L., CROCI T., LANDI M., Beta 3-adrenoceptors and intestinal motility, Fundam Clin Pharmacol, 1995, 9(4):332-342.
56. HORINOUCHI T., TANAKA Y., KOIKE K., Beta 3-adrenoceptor- mediated relaxation of guinea-pig gastric funds smooth muscle: cAMP-independent characteristics and a primary role of 4-aminopyridine-sensitive voltage-dependent K+(Kv) channels, Nippon Yakurigaku Zasshi, 2002, 120(1):109P-111P.
57. ADAMI M., CORUZZI G., SOTIROV E., BERTINI S., SOLDANI G., Pharmacological evidence for beta3 adrenoceptors in the control of rat gastric acid secretion, Dig Dis Sci, 2003, 48(2):334-339.
58. VINAY H. K., PAUL A., GOSWAMI S. S., SANTANI D., Effect of SR 58611A, a beta-3 receptor agonist, against experim- ental gastro-duodenal ulcers, Indian J Physiol Pharmacol, 2002, 46(1):36-44.
59. KURATANI K., KODAMA H., YAMAGUCHI I., Enhancement of gastric mucosal blood flow by beta-3 adrenergic agonists prevents indomethacin-induced antral ulcer in the rat, J Pharmacol Exp Ther, 1994, 270(2):559-565.
60. SHABALINA I., WIKLUND C., BENGTSSON T., JACOBSSON A., CANNON B., NEDERGAARD J., Uncoupling protein-1: involvement in a novel pathway for beta-adrenergic, cAMP- mediated intestinal relaxation, Am J Physiol Gastrointest Liver Physiol, 2002, 283(5):G1107-G1116.
61. CHAMBERLAIN P. D., JENNINGS K. H., PAUL F., CORDELL J., BERRY A., HOLMES S. D., PARK J., CHAMBERS J., SENNITT M. V., STOCK M. J., CAWTHORNE M. A., YOUNG P. W., MURPHY G. J., The tissue distribution of the human beta3-adrenoceptor studied using a monoclonal antibody: direct evidence of the beta3- adrenoceptor in human adipose tissue, atrium and skeletal muscle, Int J Obes Relat Metab Disord, 1999, 23(10):1057-1065.
62. ANTHONY A., SIM R., GUILLAUME J. L., STROSBERG A. D., DHILLON A. P., POUNDER R. E., WAKEFIELD A. J., Beta(beta)3-adrenergic receptors in human pancreatic islet and duodenal somatostatin neuroendocrine cells, Aliment Pharmacol Ther, 2000, 14(5):579-585.
63. YAMAGUCHI O., Beta3-adrenoceptors in human detrusor muscle, Urology, 2002, 59(5 Suppl 1):25-29.
64. MORITA T., IIZUKA H., IWATA T., KONDO S., Function and distribution of beta3-adrenoceptors in rat, rabbit and human urinary bladder and external urethral sphincter, J Smooth Muscle Res, 2000, 36(1):21-32.
65. PARK Y. C., TOMIYAMA Y., HAYAKAWA K., AKAHANE M., AJISAWA Y., MIYATAKE R., KIWAMOTO H., SUGIYAMA T., KURITA T., Existence of a beta3-adrenoceptor and its functional role in the human ureter, J Urol, 2000, 164(4):1364-1370.
66. CIRINO G., SORRENTINO R., DI VILLA BIANCA R., POPOLO A., PALMIERI A., IMBIMBO C., FUSCO F., LONGO N., TAJANA G., IGNARRO L. J., MIRONE V., Involvement of beta 3-adrenergic receptor activation via cyclic GMP-but not NO-dependent mechanisms in human corpus cavernosum function, Proc Natl Acad Sci U S A, 2003, 100(9):5531-5536.
67. BERKOWITZ D. E., NARDONE N. A., SMILEY R. M., PRICE D. T., KREUTTER D. K., FREMEAU R. T., SCHWINN D. A., Distribution of beta 3-adrenoceptor mRNA in human tissues, Eur J Pharmacol, 1995, 289(2):223-228.
68. ROUGET C., BARDOU M., BREUILLER-FOUCHÉ M., LOUSTALOT C., QI H., NALINE E., CROCI T., CABROL D., ADVENIER C., LEROY M. J., Beta3-adrenoceptor is the predominant beta-adrenoceptor subtype in human myometrium and its expression is up-regulated in pregnancy, J Clin Endocrinol Metab, 2005, 90(3):1644-1650.
69. BARDOU M., LOUSTALOT C., CORTIJO J., SIMON B., NALINE E., DUMAS M., ESTEVE S., CROCI T., CHALON P., FRYDMAN R., SAGOT P., MANARA L., MORCILLO E. J., ADVENIER C., Functional, biochemical and molecular biological evidence for a possible beta(3)-adrenoceptor in human near-term myometrium, Br J Pharmacol, 2000, 130(8):1960-1966.
70. DANNER I., ESCANDE D., GAUTHIER C., Beta(3)-adreno- ceptors control Cl(-) conductance in rabbit nasal epithelium, Eur J Pharmacol, 2001, 422(1-3):203-207.
71. TAMAOKI J., YAMAUCHI F., CHIYOTANI A., YAMAWAKI I., TAKEUCHI S., KONNO K., Atypical beta-adrenoceptor- (beta 3-adrenoceptor) mediated relaxation of canine isolated bronchial smooth muscle, J Appl Physiol, 1993, 74(1):297-302.
72. MARTIN C. A., ADVENIER C., Beta 3-adrenoceptors and airways, Fundam Clin Pharmacol, 1995, 9(2):114-118.
73. TAKEYAMA K., TAMAOKI J., CHIYOTANI A., SAKAI N., KANEMURA T., KONNO K., Stimulation of ciliary motility by beta 3-adrenoceptor agonist rabbit tracheal epithelium, Kokyu To Junkan, 1993, 41(10):993-997.
74. NAVEGANTES L. C., RESANO N. M., BAVIERA A. M., MIGLIORINI R. H., KETTELHUT I. C., CL 316,243, a selective beta3-adrenergic agonist, inhibits protein breakdown in rat skeletal muscle, Pflugers Arch, 2006, 451(5):617-624.
75. ROBERTS S. J., SUMMERS R. J., Cyclic AMP accumulation in rat soleus muscle: stimulation by beta2- but not beta3-adrenoceptors, Eur J Pharmacol, 1998, 348(1):53-60.
76. REHNMARK S., KOPECKÝ J., JACOBSSON A., NÉCHAD M., HERRON D., NELSON B. D., OBREGON M. J., NEDERGAARD J., CANNON B., Brown adipocytes differentiated in vitro can express the gene for the uncoupling protein thermogenin: effects of hypothyroidism and norepinephrine, Exp Cell Res, 1989, 182(1):75-83.
77. NEDERGAARD J., CANNON B., The 'novel' 'uncoupling' proteins UCP2 and UCP3: what do they really do? Pros and cons for suggested functions, Exp Physiol, 2003, 88(1):65-84.
78. NAKAMURA Y., NAGASE I., ASANO A., SASAKI N., YOSHIDA T., UMEKAWA T., SAKANE N., SAITO M., Beta 3-adrenergic agonist up-regulates uncoupling proteins 2 and 3 in skeletal muscle of the mouse, J Vet Med Sci, 2001, 63(3):309-314.
79. SCARPACE P. J., TSE C., MATHENY M., Thermoregulation with age: restoration of beta(3)-adrenergic responsiveness in brown adipose tissue by cold exposure, Proc Soc Exp Biol Med, 1996, 211(4):374-380.
80. GRANNEMAN J. G., BURNAZI M., ZHU Z., SCHWAMB L. A., White adipose tissue contributes to UCP1-independent thermogenesis, Am J Physiol Endocrinol Metab, 2003, 285(6):E1230-E1236.
81. VALET P., GRUJIC D., WADE J., ITO M., ZINGARETTI M. C., SOLOVEVA V., ROSS S. R., GRAVES R. A., CINTI S., LAFONTAN M., LOWELL B. B., Expression of human alpha 2- adrenergic receptors in adipose tissue of beta 3-adrenergic receptor-deficient mice promotes diet-induced obesity, J Biol Chem, 2000, 275(44):34797-34802.
82. COLLINS S., CAO W., ROBIDOUX J., Learning new tricks from old dogs: beta-adrenergic receptors teach new lessons on firing up adipose tissue metabolism, Mol Endocrinol, 2004, 18(9):2123-2131.
83. DE SOUZA C. J., BURKEY B. F., Beta 3-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans, Curr Pharm Des, 2001, 7(14):1433-1449.
84. LAFONTAN M., ARNER P., Application of in situ microdialysis to measure metabolic and vascular responses in adipose tissue, Trends Pharmacol Sci, 1996, 17(9):309-313.
85. ENOCKSSON S., SHIMIZU M., LÖNNQVIST F., NORDENSTRÖM J., ARNER P., Demonstration of an in vivo functional beta 3- adrenoceptor in man, J Clin Invest, 1995, 95(5):2239-2245.
86. ARNER P., Differences in lipolysis between human subcutaneous and omental adipose tissues, Ann Med, 1995, 27(4):435-438.
87. WEYER C., GAUTIER J. F., DANFORTH E. JR., Development of beta 3-adrenoceptor agonists for the treatment of obesity and diabetes - an update, Diabetes Metab, 1999, 25(1):11-21.
88. MILAGRO F. I., GÓMEZ-AMBROSI J., FORGA L., MARTÍNEZ J. A., A beta3-adrenergic agonist increases muscle GLUT1/ GLUT4 ratio, and regulates liver glucose utilization in diabetic rats, Diabetes Obes Metab, 1999, 1(2):97-104.
89. CHERNOGUBOVA E., CANNON B., BENGTSSON T., Norepinephrine increases glucose transport in brown adipocytes via beta3-adrenoceptors through a cAMP, PKA, and PI3-kinase-dependent pathway stimulating conventional and novel PKCs, Endocrinology, 2004, 145(1):269-280.
90. LIU X., PÉRUSSE F., BUKOWIECKI L. J., Mechanisms of the antidiabetic effects of the beta 3-adrenergic agonist CL-316243 in obese Zucker-ZDF rats, Am J Physiol, 1998, 274(5 Pt 2):R1212-R1219.
91. WEYER C., TATARANNI P. A., SNITKER S., DANFORTH E. JR., RAVUSSIN E., Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3- adrenoceptor agonist in humans, Diabetes, 1998, 47(10):1555-1561.
92. FISHER M. H., AMEND A. M., BACH T. J., BARKER J. M., BRADY E. J., CANDELORE M. R., CARROLL D., CASCIERI M. A., CHIU S. H., DENG L., FORREST M. J., HEGARTY-FRISCINO B., GUAN X. M., HOM G. J., HUTCHINS J. E., KELLY L. J., MATHVINK R. J., METZGER J. M., MILLER R. R., OK H. O., PARMEE E R., SAPERSTEIN R., STRADER C D., STEARNS R A., MACINTYRE D. E. et al., A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys, J Clin Invest, 1998, 101(11):2387-2393.